What is this vaccine against covid-19? : vimarsana.com

What is this vaccine against covid-19?


By Dr. Kavindya Marapana
COVID-19 has impacted millions of lives worldwide. Sri Lanka reported its first case of COVID-19 on 27thJanuary 2020 and since then the epidemic has affected Sri Lanka significantly, especially since the second wave of COVID-19 in October 2020, causing a severe health, economic and social burden. Globally, whilst many people may have asymptomatic infection, around 40% of the infected persons develop a range of mild symptoms which include fever, a new and continuous cough, shortness of breath, sore throat, fatigue, loss of appetite, diarrhoea, etc. Only around 15% of the patients develop severe complications such as pneumonia, and out them around 5% suffer from life-threatening diseases including severe respiratory distress syndrome, thromboembolic events and multi-organ failure. In Sri Lanka, 79, 999 cases have been identified to the date of writing and although the incidence of COVID-19 related complications seem to be low, 445 deaths have been reported up-to-date, including paediatric deaths. COVID -19 is also believed to have long-term effects on neurological system which is still in research stage.

Related Keywords

Sri Lanka , India , Sri Lankans , Astrazeneca Chadox , Kavindya Marapana , Chintha Karunasekara , National Advisory Committee Of Communicable Diseases , Astrazeneca , University Of Oxford , Ministry Of Health , Serum Institute Of India , National Advisory Committee , Communicable Diseases , Consultant Microbiologist , Lady Ridgeway Hospital , Serum Institute , Virus Vaccine Recombinant , South Asian , ஸ்ரீ லங்கா , இந்தியா , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , தொடர்பு கொள்ளக்கூடியது நோய்கள் , ஆலோசகர் நுண்ணுயிரியலாளர் , பெண் ரிட்ஜ்வே மருத்துவமனை , சீரம் நிறுவனம் , வைரஸ் தடுப்பூசி மறுசீரமைப்பு , தெற்கு ஆசிய ,

© 2025 Vimarsana